About Us
Medgen Life Science (迈捷生命科学) is a Shenzhen-based medical device company dedicated to developing and commercializing regenerative repair materials for orthopedic and dental applications.
Our Mission
Medgen Life Science was founded by a team with deep expertise in biomaterials science and medical device commercialization. We are committed to advancing the standard of care in bone regeneration through innovative, clinically validated products that address unmet needs in orthopedic and dental surgery.
The company has established strong academic collaborations that provide access to world-class research and a rigorous scientific foundation for product development.
Our product portfolio spans from injectable bone void fillers to xenograft materials, all developed using proprietary processing technologies that preserve the biological characteristics of natural bone tissue. (BoneSwift™) / (PoroGraft®)
Key Certifications
- National High-Tech Enterprise
- National Specialized & Novel SME
- GMP-compliant 10,000-grade cleanroom facility
- Multi-country regulatory approvals (China, Vietnam, Indonesia)
Technology Platform
Our product development is built on three core technology platforms.
Proprietary processing techniques that preserve the native collagen matrix and mineral composition of natural bone tissue, yielding materials with superior osteoconductive properties compared to synthetic alternatives.
See BoneSwift™ →Precision-engineered pore structures that optimize cell infiltration, nutrient transport, and vascularization. Our materials feature interconnected macro- and micro-porosity tailored for specific clinical applications.
See PoroGraft® →Innovative ready-to-use delivery systems that eliminate intraoperative mixing, reduce procedure time, and ensure consistent material performance. BoneSwift™ is China’s first pre-filled injectable bone repair product.
See BoneSwift™ →Company Milestones
A timeline of key events in Medgen’s journey from founding to dual NMPA approvals.
Company founded in Shenzhen
Medgen Life Science established with a focus on regenerative repair materials for orthopedic and dental surgery.
Entered the medical device market
Began building clinical relationships and commercial infrastructure in the medical device market.
Recognized as a National High-Tech Enterprise
Received National High-Tech Enterprise certification, affirming Medgen's R&D capabilities and innovation focus.
Won national innovation competition awards
Recognized at the national level for innovation in regenerative repair materials. Ranked in the national top 100 "Sci-Tech China" program for medical device startups.
BoneSwift™ clinical trial completed
Multi-center clinical trial for BoneSwift™ injectable bone repair material completed with excellent results.
View Details →Completed Series A funding
Raised tens of millions of RMB in Series A financing to accelerate product development and regulatory submissions.
Completed Series A+ funding
Closed a follow-on Series A+ round led by Yuansheng Ventures, strengthening the balance sheet ahead of dual product launches.
BoneSwift™ NMPA approval — China's first pre-filled injectable bone repair material
Received NMPA Class III medical device approval for BoneSwift™, a breakthrough pre-filled injectable bone repair material.
View Details →PoroGraft® NMPA approval — China's first porcine-derived oral bone graft
Received NMPA Class III approval for PoroGraft®, a natural-derived xenograft material for guided bone regeneration.
View Details →BoneSwift™ Vietnam Class D approval
BoneSwift™ received the highest Class D medical device classification in Vietnam, marking Medgen's first international market entry.
View Details →Recognized as National Specialized & Novel SME
Awarded the 专精特新 (Specialized, Refined, Differentiated, Novel) designation by the Ministry of Industry and Information Technology.
PoroGraft® Vietnam Class D approval
PoroGraft® received the highest Class D approval in Vietnam, completing the dental product line's international registration.
View Details →Latest News
View All →In 2025, Medgen Life Science achieved major breakthroughs in product innovation, international expansion, and industry standard-setting, delivering a year of high-quality growth.
Medgen's PoroGraft® oral bone filling material receives Class D medical device registration in Vietnam — the highest risk classification — becoming the company's third product approved in Vietnam and marking the systematic deployment of a multi-product portfolio in Southeast Asia.
Medgen Life Science has been named a "Quality, Safe, and Trusted Medical Aesthetics Service Provider" for the fourth consecutive year, delivering regenerative material solutions built to medical-grade standards.
Get in Touch
Interested in learning more about Medgen Life Science? We welcome inquiries from hospitals, distributors, research institutions, and potential partners.
Contact Us